Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Ramesh Srinivasan Announces Adoption of Stock Trading Plan

Elaine Mendonca by Elaine Mendonca
January 23, 2024
in Breaking News
0
Finance_Financialization
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

On January 23, 2024, Ramesh Srinivasan, the esteemed President and CEO of Agilysys Inc, has made an official announcement regarding his forthcoming adoption of a stock trading plan. In this strategic move, Srinivasan intends to divest himself of a substantial number of Agilysys common stock shares, estimated to be around 300,000. It is anticipated that these shares will primarily stem from his exercise of stock-settled appreciation rights. This significant revelation was unveiled through a filing with the Securities and Exchange Commission (SEC) on the aforementioned date. Notably, Ramesh Srinivasan has been diligently leading Agilysys as its President and Chief Executive Officer since January 2017.

AGYS Stock Performance on January 23, 2024: Mixed Results and Cautionary Considerations

On January 23, 2024, AGYS stock displayed interesting performances. The stock was trading near the top of its 52-week range and positioned above its 200-day simple moving average, indicating positive price momentum. However, the price of AGYS shares experienced a significant decrease of $3.07 since the market last closed, accounting for a 3.55% decrease in value. The stock opened at $88.40, $1.69 higher than its previous close. While the stock’s position above its 200-day simple moving average suggests a positive trend, the recent drop in price might be a cause for caution. Investors should closely monitor the stock’s performance and consider various factors before making any investment decisions. It is important to note that the information provided is based on historical data from a specific date and does not guarantee future performance. Stock prices are subject to fluctuations influenced by various market factors, including economic conditions, industry trends, and company-specific news. Therefore, thorough research and analysis are essential before making any investment decisions. In conclusion, AGYS stock displayed mixed performances on January 23, 2024. Investors should exercise caution and consider multiple factors before making any investment decisions related to AGYS stock.

Impressive Financial Growth: AGYS Stock Demonstrates Strong Performance on January 23, 2024

On January 23, 2024, AGYS stock demonstrated a strong performance, reflecting the company’s positive financial results. The data, sourced from CNN Money, reveals significant growth in various key indicators, including total revenue, net income, and earnings per share (EPS).

AGYS reported a total revenue of $198.06 million over the past year, representing a notable increase of 21.78% compared to the previous year. The company’s quarterly revenue for Q3 stood at $60.57 million, indicating a 3.33% increase since the previous quarter.

Net income also experienced substantial growth for AGYS. Over the past year, the company reported a net income of $14.58 million, marking an impressive increase of 125.1% compared to the previous year. The Q3 net income surged to $77.14 million, showcasing an extraordinary growth rate of 1597.27% since the previous quarter.

Furthermore, AGYS’s earnings per share (EPS) demonstrated remarkable growth. The company reported an EPS of $0.49 over the past year, signifying a substantial increase of 169.81% compared to the previous year. The Q3 EPS surged to $2.85, showcasing an extraordinary growth rate of 1722.25% since the previous quarter.

Overall, AGYS’s stock performance on January 23, 2024, was impressive, reflecting the company’s strong financial results. The significant growth in total revenue, net income, and EPS indicates AGYS’s ability to expand its business and generate higher profits. These positive indicators make AGYS an attractive investment option, as the company continues to demonstrate promising growth potential. Investors should closely monitor AGYS’s performance and consider the company for their investment portfolios.

Tags: AGYS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Automotive Stock Market Today

Fiskers Shares Surge on Positive Business Update and Debt Reduction

Telecommunications Industry stock Trading

ATTs Quarterly Financial Results and Stock Price Impact

Finance_Cash

Analyst Perspectives and Price Targets for BlackLine

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com